XML 32 R25.htm IDEA: XBRL DOCUMENT
v3.25.2

Stock-Based Compensation | 6 Months Ended
--- | ---
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | 17) STOCK-BASED COMPENSATION The Company accounts for stock-based compensation under the fair value recognition provisions of ASC Topic 718 - Compensation - Stock Compensation. The Company recognizes stock-based compensation cost over the award’s requisite service period on a straight-line basis for time-based restricted stock grants and performance-based restricted stock grants. The Company records forfeitures as they occur for all stock-based compensation. The following table presents the Company's total stock-based compensation expense:
| Three Months Ended June 30, |  |  | Six Months Ended June 30, |
| 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Employee stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |
Pre-tax | $ | 1,348 |  |  | $ | 667 |  |  | $ | 1,946 |  |  | $ | 1,037 |
Post-tax (1) |  | 1,065 |  |  |  | 527 |  |  |  | 1,537 |  |  |  | 819 |
Director stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |
Pre-tax |  | 123 |  |  |  | 113 |  |  |  | 258 |  |  |  | 171 |
Post-tax (1) |  | 97 |  |  |  | 89 |  |  |  | 204 |  |  |  | 135 |
(1) The after-tax amounts are determined using the 21% corporate federal tax rate. The Company had approximately $5,535,000 of unrecognized stock compensation expense at June 30, 2025 related to non-vested stock-based compensation granted, which it expects to recognize over a weighted-average period of approximately 2.0 years. The Company had approximately $426,000 of unrecognized director stock-based compensation expense at June 30, 2025 related to non-vested director stock-based compensation granted, which it expects to recognize over a weighted-average period of approximately 0.9 years. Restricted stock, restricted stock units and performance stock units Stock-based compensation cost for restricted stock awards, restricted stock units and performance stock units is measured based on the closing fair market value of the Company's common stock on the date of grant, which vest in equal installments over the requisite service period of typically three years. Restricted stock awards granted to non-employee directors vest over a one-year period. Each restricted stock unit and performance stock unit represents the Company's obligation to deliver to the holder one share of common stock upon vesting. Performance stock units vest based on the Company's return on average equity compared to a defined group of peer companies. On the grant date, the Company issues the target number of performance stock units. They are subject to forfeitures if performance goals are not met. The actual number of performance stock units earned can vary from zero to 150 percent of the target for the awards. The Company granted 413,405 and 471,746 shares of restricted common stock during the three months ended June 30, 2025 and 2024, respectively, which had a weighted-average grant date fair value of $11.48 and $7.18, respectively. The Company granted 447,237 and 501,746 shares of restricted common stock during the six months ended June 30, 2025 and 2024, respectively, which had a weighted-average grant date fair value of $11.52 and $7.32, respectively. The following table presents certain information related to the activity of the Company's non-vested restricted common stock grants:
| Number of Restricted Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of December 31, 2024 |  | 606,411 |  |  | $ | 6.23 |
Granted |  | 447,237 |  |  |  | 11.52 |
Less: Forfeited |  | 1,009 |  |  |  | 11.59 |
Less: Vested |  | 490,623 |  |  |  | 5.24 |
Outstanding as of June 30, 2025 |  | 562,016 |  |  | $ | 10.10 |
Stock options Stock option fair value was estimated on the grant date using the Black-Scholes-Merton formula. Stock options vest in equal installments over the requisite service period of typically three years. The following weighted-average assumptions were used to value the stock options granted:
| 2025 |  |  | 2024 |
Expected annual dividend yield |  | — | % |  |  | — | %
Expected volatility |  | 88.51 | % |  |  | 86.92 | %
Risk-free interest rate |  | 3.87 | % |  |  | 4.37 | %
Expected term | 6 years |  |  | 6 years |
The expected annual dividend yield for options granted during 2025 and 2024 is based on no dividends being paid in future quarters. The expected volatility is a historical volatility calculated based on the daily closing prices over a period equal to the expected term. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date. Expected term takes into account the three-year graded vesting term and the 10-year contractual term of the option. The Company granted 76,141 and 196,275 stock options for the three and six months ended June 30, 2025 and 2024, respectively, which had a weighted average grant date fair value of $11.63 and $4.82 per share, respectively. The following table presents certain information related to the activity of the Company's stock option grants:
| Number of Stock Options |  |  | Weighted Average Exercise Prices |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (2) |
Outstanding as of December 31, 2024 |  | 1,130,035 |  |  | $ | 4.12 |  |  |  | 7.21 |  |  | $ | 10,202,000 |
Granted |  | 76,141 |  |  |  | 11.63 |  |  |  | — |  |  |  | — |
Less: Forfeited |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Less: Expired |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Less: Exercised |  | 240,446 |  |  |  | 3.17 |  |  |  | — |  |  |  | — |
Outstanding as of June 30, 2025 |  | 965,730 |  |  | $ | 4.95 |  |  |  | 7.01 |  |  | $ | 6,284,000 |
Vested as of June 30, 2025 ⁽¹⁾ |  | 1,475,570 |  |  | $ | 4.24 |  |  |  | 6.53 |  |  | $ | 5,791,000 |
Exercisable as of June 30, 2025 |  | 799,869 |  |  | $ | 4.24 |  |  |  | 6.53 |  |  | $ | 5,791,000 |
(1) The vested shares are calculated based on all vested shares at June 30, 2025, inclusive of those that have since expired. The weighted average exercise prices, weighted-average remaining contractual term and aggregate intrinsic value is calculated based on only vested shares that are outstanding and exercisable at June 30, 2025. (2) Presented in ones.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration